A comprehensive analysis of viability assays for Giardia lamblia and Trichomonas vaginalis trophozoites: a systematic review
The Journal of Infection in Developing Countries · 2025
DOI: 10.3855/jidc.21084 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift The Journal of Infection in Developing Countries, 2025. Verfasst von Susie Sequeira und 2 weiteren Autor:innen. Beteiligte Einrichtung: ESS, Polytechnic of Porto, rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal. Hauptthemen laut MEDLINE: Trichomonas vaginalis, Giardia lamblia, Trophozoites, Antiprotozoal Agents. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Giardia lamblia and Trichomonas vaginalis are flagellated protozoan parasites that often cause asymptomatic infections but may lead to gastrointestinal or genitourinary symptoms. Improved treatment options are needed due to emerging resistance. However, selecting an appropriate method for assessing the in vitro susceptibility of G. lamblia and T. vaginalis in the presence of potential therapeutic compounds remains challenging due to the variability in these methods. This study aimed to provide an overview of commonly employed methods for determining trophozoite viability in the presence of potential therapeutic compounds and to propose a standardized viability assay for susceptibility testing for G. lamblia and T. vaginalis. Methodology: A systematic literature review was conducted according to the preferred reporting items for systematic reviews and meta-analyses (PRISMA) 2020 statement, using databases including MEDLINE, ScienceDirect, and Web of Science, with the following search equation: “in vitro” AND “method” AND (“susceptibility” OR “viability” OR “sensitivity”) AND (“giardia” OR “trichomonas”).
Results
The search identified 32 experimental studies with diverse viability assays. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, adherence inhibition assay, and [3H]-thymidine incorporation assay were prominent for G. lamblia. The trypan blue assay, motility assessment, and resazurin assay were frequently used for T. vaginalis. These findings underscore the diversity in viability assessment methods, highlighting the importance of standardizing viability assays to ensure accurate and reproducible results in drug susceptibility studies.
Conclusions
The fluorometric resazurin assay has emerged as a suitable choice for standardization in both parasites, offering cost-effectiveness, reliability, and ease of use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ESS, Polytechnic of Porto, rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.
- REQUIMTE/LAQV, ESS, Polytechnic of Porto, rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal.
Zitieren
APA
Sequeira, S., Sousa, M., & Cruz, A. (2025). A comprehensive analysis of viability assays for Giardia lamblia and Trichomonas vaginalis trophozoites: a systematic review. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.21084
Vancouver
Sequeira S, Sousa M, Cruz A. A comprehensive analysis of viability assays for Giardia lamblia and Trichomonas vaginalis trophozoites: a systematic review. The Journal of Infection in Developing Countries. 2025. doi:10.3855/jidc.21084
BibTeX
@article{Sequeira2025,
author = {Sequeira, Susie and Sousa, Mariana and Cruz, Agostinho},
title = {A comprehensive analysis of viability assays for Giardia lamblia and Trichomonas vaginalis trophozoites: a systematic review},
journal = {The Journal of Infection in Developing Countries},
year = {2025},
doi = {10.3855/jidc.21084}
}
EUVIMED